Mergers and Acquisitions

Mergers and Acquisitions Articles

Canadian marijuana grower Hexo reported a big jump in revenues for its fiscal second quarter, one day after announcing a major acquisition.
The brokerage firm Raymond James sees a mixed view of Newmont and Barrick after the deal in a report from March 12, 2019.
Phoenix-based marijuana company Harvest Health & Recreation has agreed to acquire Chicago-based Verano Holdings for $850 million in the largest acquisition the sector has ever recorded.
Mellanox shares jumped on Monday after the announced that Nvidia would be acquiring the firm.
As expected, Newmont Mining this morning rejected last week's offer of an $18 billion all-stock merger with rival Barrick.
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Technology giants should consider that they have been put on notice. The Federal Trade Commission is creating a task force dedicated to monitoring competition in U.S. technology markets.
Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences biotechnology instrument division to Danaher is one of those fairy...
Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions...
Investors should understand from the get-go that this gold merger would seem to be unlikely from a shareholder voting and regulatory stance. The reaction in the shares also seems to reflect some...
Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired by Swiss health care giant Roche, which is looking to add to its portfolio.
Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected to be completed by the end of this year.
Clementia Pharmaceuticals has entered into an agreement to be acquired by French pharmaceutical company Ipsen.
Berkshire Hathaway will release its 2018 annual report to its shareholders on Saturday, February 23, 2019. While some investors might not care what Warren Buffett has to say, this year's letter might...
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium